ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crescenzo, D. G.
Right arrow Articles by Hopkins, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crescenzo, D. G.
Right arrow Articles by Hopkins, R. A.

The Annals of Thoracic Surgery, Vol 55, 25-30, Copyright © 1993 by The Society of Thoracic Surgeons


ARTICLES

Human cryopreserved homografts: electron microscopic analysis of cellular injury

DG Crescenzo, SL Hilbert, RH Messier Jr, PW Domkowski, MK Barrick, PL Lange, VJ Ferrans, RB Wallace and RA Hopkins
Georgetown University School of Medicine, Washington, DC.

Twenty-five human cryopreserved valves with harvest-related warm ischemic times (WITs) ranging from 0 to 20 hours were studied using transmission electron microscopy to characterize the effects of harvesting and preservation on leaflet matrix cells. The valves were divided into seven groups on the basis of WIT and processed using standard transmission electron microscopic methods. Each cell (528 micrographs) was graded for reversible and irreversible cellular injury and subjected to a Cochran-Mantel-Haenszel trend analysis. Our results demonstrated a progression in cellular injury with increasing WIT. During the first 12 hours of warm ischemia, reversible cellular injury predominated (0.0%, 30.0%, 51.2%, 31.3%, 35.1%, 45.1%, and 40.0% at WITs of 0, 1, 2, 8, 12, 16, and 20 hours, respectively). A positive correlation (p < 0.0001) between increasing WIT and reversible cellular injury through the first 12 hours was observed. Minimal morphologic evidence of irreversible injury was noted in valves harvested with less than 12 hours of warm ischemia; however, after 12 hours there was a marked increase (0.0%, 0.0%, 4.7%, 2.4%, 2.7%, 31.4%, and 40.0% at WITs of 0, 1, 2, 8, 12, 16, and 20 hours, respectively) in irreversible cellular injury (p < 0.001 between 12 and 20 hours WIT). These data demonstrate a progression in cellular injury with increasing WIT. There was virtually no morphologic injury in valves with harvest-related WITs less than 2 hours and minimal irreversible cellular injury observed in valves exposed to 12 hours or less of warm ischemia. If cellular viability is critical to homograft durability then harvest-related warm ischemia may need to be restricted to 12 hours.


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. C. Song, L. Y. Yao, J. M. Kneebone, and F. M. Lupinetti
EFFECT OF CRYOPRESERVATION AND HISTOCOMPATIBILITY ON TYPE I PROCOLLAGEN GENE EXPRESSION IN AORTIC VALVE GRAFTS
J. Thorac. Cardiovasc. Surg., September 1, 1997; 114(3): 421 - 427.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Wassenaar, W. A. Bax, R.-J. van Suylen, V. D. Vuzevski, and E. Bos
EFFECTS OF CRYOPRESERVATION ON CONTRACTILE PROPERTIES OF PORCINE ISOLATED AORTIC VALVE LEAFLETS AND AORTIC WALL
J. Thorac. Cardiovasc. Surg., January 1, 1997; 113(1): 165 - 172.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Baskett, D. B. Ross, M. A. Nanton, and D. A. Murphy
FACTORS IN THE EARLY FAILURE OF CRYOPRESERVED HOMOGRAFT PULMONARY VALVES IN CHILDREN: PRESERVED IMMUNOGENICITY?
J. Thorac. Cardiovasc. Surg., November 1, 1996; 112(5): 1170 - 1179.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. G. Hazekamp, D. R. Koolbergen, J. Braun, H. Sugihara, C. J. Cornelisse, Y. A. Goffin, and H. A. Huysmans
In situ hybridization: A new technique to determine the origin of fibroblasts in cryopreserved aortic homograft valve explants
J. Thorac. Cardiovasc. Surg., July 1, 1995; 110(1): 248 - 257.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1993 by The Society of Thoracic Surgeons.